Update On Pending Merger Between Verde Bio and SensaSure Technologies

Double exposure of business handshake and oil refinery plant. Business people shaking hands in the office. Finishing successful meeting

Oil and gas company Verde Bio (VBHI) issued an update regarding its pending merger with SensaSure Technologies (SSTC). In the update the company announced that the registration statement on Form S-4 has been declared effective by the Securities and Exchange Commission. A special meeting will be held for each company’s shareholders on May 9th 2024. The shareholders who have been sent the Proxy Statement/Prospectus are urged to read the document and vote “FOR” ALL PROPOSALS ahead of the special meetings by phone, Internet or by proxy card. Further information on this matter can be found in the official release.

The merger is expected to close by the end of May 2024.

About SensaSure Technologies, Inc.

Until November 2023, SensaSure Technologies, Inc. (OTCQB: SSTC) was a medical technology or “MedTech” company that supplied a simple device and method to collect a breath sample for lab-based analysis. Subsequent to the six months ended October 31, 2023, management of SensaSure has been in the process of establishing a new business segment to develop energy related businesses which led to the entry into the pending Merger transaction.

About Verde Bio Holdings, Inc.

Verde Bio Holdings, Inc. (OTC: VBHI) is an oil and gas company engaged in the acquisition and management of mineral and royalty interests in lower risk, onshore oil and gas properties within the major oil and gas plays in the U.S. The Company’s dual-focused growth strategy relies primarily on leveraging management’s expertise to grow through the strategic acquisition of revenue producing royalty interest and strategic and opportunistic non-operated working interests.

Disclaimer

This communication was produced by Prism MarketView, an affiliate of PCG Advisory Inc., (together “PCG”). PCG is an integrated investor relations, communications and strategic advisory firm. The information contained on this is ‘Paid Advertising’ for purposes of Section 17(b) of the Securities Act of 1933, as amended (together with the rules and regulations there under, the “Securities Act”). “PCG” and its affiliates are compensated by respective clients for publicizing information relating to its client’s securities. For more information in terms of compensation received for services provided by PCG, see the pertinent advertising materials relating to the respective client. By accessing this Site and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy…

Read Full Disclaimer

Share This Article

 

About the Author

Update On Pending Merger Between Verde Bio and SensaSure Technologies

Ashlee Vogenthaler

Markets Editor